Shanghai Sunstem Biotechnology Co., Ltd.   Report issue

For profit Phase 2
Founded: Shanghai China (2005)

Organization Overview

First Clinical Trial
2020
NCT04567069
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Shandong Sunstem Biotechnology Co.,Ltd. | Shanghai Sunstem Biotechnology Co., Ltd.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Stomach Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 5